These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 16079887

  • 1. Eradication of hepatocellular carcinoma xenografts by radiolabelled, lipiodol-inducible gene therapy.
    Kawashita Y, Ohtsuru A, Miki F, Kuroda H, Morishita M, Kaneda Y, Hatsushiba K, Kanematsu T, Yamashita S.
    Gene Ther; 2005 Nov; 12(22):1633-9. PubMed ID: 16079887
    [Abstract] [Full Text] [Related]

  • 2. Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation.
    Kawashita Y, Ohtsuru A, Kaneda Y, Nagayama Y, Kawazoe Y, Eguchi S, Kuroda H, Fujioka H, Ito M, Kanematsu T, Yamashita S.
    Hum Gene Ther; 1999 Jun 10; 10(9):1509-19. PubMed ID: 10395376
    [Abstract] [Full Text] [Related]

  • 3. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
    Wang WD, Chen ZT, Li DZ, Duan YZ, Wang ZX, Cao ZH.
    Ai Zheng; 2004 Jul 10; 23(7):788-93. PubMed ID: 15248913
    [Abstract] [Full Text] [Related]

  • 4. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A, Uto H, Moriuchi A, Nagata K, Onaga Y, Onaga M, Hori T, Hirono S, Hayashi K, Tamaoki T, Tsubouchi H.
    Cancer Res; 2001 Apr 01; 61(7):3016-21. PubMed ID: 11306481
    [Abstract] [Full Text] [Related]

  • 5. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
    Greco O, Joiner MC, Doleh A, Powell AD, Hillman GG, Scott SD.
    Gene Ther; 2006 Feb 01; 13(3):206-15. PubMed ID: 16307003
    [Abstract] [Full Text] [Related]

  • 6. Preclinical and therapeutic utility of HVJ liposomes as a gene transfer vector for hepatocellular carcinoma using herpes simplex virus thymidine kinase.
    Hasegawa H, Shimada M, Yonemitsu Y, Utsunomiya T, Gion T, Kaneda Y, Sugimachi K.
    Cancer Gene Ther; 2001 Apr 01; 8(4):252-8. PubMed ID: 11393277
    [Abstract] [Full Text] [Related]

  • 7. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model.
    Bilbao R, Gérolami R, Bralet MP, Qian C, Tran PL, Tennant B, Prieto J, Bréchot C.
    Cancer Gene Ther; 2000 May 01; 7(5):657-62. PubMed ID: 10830712
    [Abstract] [Full Text] [Related]

  • 8. Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
    Sakai Y, Kaneko S, Nakamoto Y, Kagaya T, Mukaida N, Kobayashi K.
    Cancer Gene Ther; 2001 Oct 01; 8(10):695-704. PubMed ID: 11687892
    [Abstract] [Full Text] [Related]

  • 9. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
    Mawatari F, Tsuruta S, Ido A, Ueki T, Nakao K, Kato Y, Tamaoki T, Ishii N, Nakata K.
    Cancer Gene Ther; 1998 Oct 01; 5(5):301-6. PubMed ID: 9824049
    [Abstract] [Full Text] [Related]

  • 10. [Experimental study on lung carcinoma-targeted suicide gene therapy induced by irradiation].
    Wang WD, Chen ZT, Li DZ, Duan YZ, Cao ZH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb 01; 26(2):84-7. PubMed ID: 12783658
    [Abstract] [Full Text] [Related]

  • 11. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
    Ido A, Nakata K, Kato Y, Nakao K, Murata K, Fujita M, Ishii N, Tamaoki T, Shiku H, Nagataki S.
    Cancer Res; 1995 Jul 15; 55(14):3105-9. PubMed ID: 7541712
    [Abstract] [Full Text] [Related]

  • 12. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
    Zhao Y, Zhang X, Hui H.
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun 15; 7(2):113-5. PubMed ID: 10488424
    [Abstract] [Full Text] [Related]

  • 13. Suicide gene therapy using AAV-HSVtk/ganciclovir in combination with irradiation results in regression of human head and neck cancer xenografts in nude mice.
    Kanazawa T, Mizukami H, Okada T, Hanazono Y, Kume A, Nishino H, Takeuchi K, Kitamura K, Ichimura K, Ozawa K.
    Gene Ther; 2003 Jan 15; 10(1):51-8. PubMed ID: 12525837
    [Abstract] [Full Text] [Related]

  • 14. Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer.
    Isomoto H, Ohtsuru A, Braiden V, Iwamatsu M, Miki F, Kawashita Y, Mizuta Y, Kaneda Y, Kohno S, Yamashita S.
    Oncol Rep; 2006 Mar 15; 15(3):629-35. PubMed ID: 16465423
    [Abstract] [Full Text] [Related]

  • 15. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
    Kawashita Y, Deb NJ, Garg M, Kabarriti R, Alfieri A, Takahashi M, Roy-Chowdhury J, Guha C.
    Radiat Res; 2014 Aug 15; 182(2):191-200. PubMed ID: 24972258
    [Abstract] [Full Text] [Related]

  • 16. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression.
    Kaneko S, Hallenbeck P, Kotani T, Nakabayashi H, McGarrity G, Tamaoki T, Anderson WF, Chiang YL.
    Cancer Res; 1995 Nov 15; 55(22):5283-7. PubMed ID: 7585589
    [Abstract] [Full Text] [Related]

  • 17. Cre/loxP system controlled by specific promoter for radiation-mediated gene therapy of hepatoma.
    Hsieh YJ, Liu RS, Hwu L, Ke CC, Wang FH, Wang HE, Chen FD.
    Anticancer Res; 2007 Nov 15; 27(3B):1571-9. PubMed ID: 17595778
    [Abstract] [Full Text] [Related]

  • 18. Reduced growth in response to ganciclovir treatment of subcutaneous xenografts expressing HSV-tk in the vascular compartment.
    Mavria G, Porter CD.
    Gene Ther; 2001 Jun 15; 8(12):913-20. PubMed ID: 11426331
    [Abstract] [Full Text] [Related]

  • 19. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
    Majumdar AS, Hughes DE, Lichtsteiner SP, Wang Z, Lebkowski JS, Vasserot AP.
    Gene Ther; 2001 Apr 15; 8(7):568-78. PubMed ID: 11319624
    [Abstract] [Full Text] [Related]

  • 20. HVJ-liposome-mediated transfection of HSVtk gene driven by AFP promoter inhibits hepatic tumor growth of hepatocellular carcinoma in SCID mice.
    Hirano T, Kaneko S, Kaneda Y, Saito I, Tamaoki T, Furuyama J, Tamaoki T, Kobayashi K, Ueki T, Fujimoto J.
    Gene Ther; 2001 Jan 15; 8(1):80-3. PubMed ID: 11402306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.